MYL(600993) 证券之星· Zheng Quan Zhi Xing·2025-05-28 09:22Core Viewpoint - The company, Mayinglong Pharmaceutical Group Co., Ltd., is set to hold a performance briefing on June 6, 2025, to discuss its 2024 annual results and Q1 2025 performance, allowing for investor interaction and questions [1][2]. Group 1: Meeting Details - The performance briefing is scheduled for June 6, 2025, from 10:30 AM to 11:30 AM [2][3]. - The meeting will take place at the Shanghai Stock Exchange Roadshow Center, accessible via the website: https://roadshow.sseinfo.com/ [2][3]. - The format of the meeting will be a combination of video and online interaction, enabling real-time communication with investors [2][3]. Group 2: Participation Information - Investors can submit questions from May 29, 2025, to June 5, 2025, by visiting the "Pre-Question Collection" section on the Shanghai Stock Exchange Roadshow Center website or by emailing ir@mayinglong.cn [3]. - During the briefing, the company will address commonly asked questions from investors within the scope of information disclosure [2][3]. Group 3: Key Personnel - Key participants in the meeting will include Chairman Chen Ping, General Manager Xia Youzhang, Secretary of the Board Ma Qian, CFO Mao Tao, and Independent Director Mao Peng [2].